Need Help?

H3Africa - An integrated approach to the identification of genetic determinants of susceptibility to trypanosomiasis

The objective of the TrypanoGEN project is to discover genetic variants associated with different responses to sleeping sickness infection. The project was designed in two phases:Phase 1) Variant discovery; 222 samples were sequenced to approximately 10X coverage on an Illumina 2500 with 2x150bp reads, at the University of Liverpool Center for Genomic Research. In addition, 77 samples from Cameroon and Zambia were sequenced to approximately 30X Coverage at Baylor College of Medicine. The sequenced reads were mapped onto the 1000 genomes project human_g1k_v37_decoy reference genome using BWA. The SNP calling on all the samples was done using the genome analysis tool kit GATK v3.4. Samples were selected from seven populations where Trypanosomiasis is endemic: Nilo-Saharan speakers from North-West Uganda and Niger-Congo speakers from South-East Uganda, DRC, Ivory Coast, Guinea, Cameroon and Zambia. The samples included 182 controls, 97 cases, 17 latent infections and 3 suspect cases. Phase 2) Variants discovered in Phase 1 will be used in the development of the H3Africa SNP chip. This chip will then be used in a GWAS study to identify variants associated with trypanosomiasis.

Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data

Dataset ID Description Technology Samples
EGAD00001005076 233
Publications Citations
Candidate gene polymorphisms study between human African trypanosomiasis clinical phenotypes in Guinea.
PLoS Negl Trop Dis 11: 2017 e0005833
15
A polymorphism in the haptoglobin, haptoglobin related protein locus is associated with risk of human sleeping sickness within Cameroonian populations.
PLoS Negl Trop Dis 11: 2017 e0005979
11
No evidence for association between APOL1 kidney disease risk alleles and Human African Trypanosomiasis in two Ugandan populations.
PLoS Negl Trop Dis 12: 2018 e0006300
10
Association of APOL1 renal disease risk alleles with Trypanosoma brucei rhodesiense infection outcomes in the northern part of Malawi.
PLoS Negl Trop Dis 13: 2019 e0007603
6
Copy number variation in human genomes from three major ethno-linguistic groups in Africa.
BMC Genomics 21: 2020 289
5
High Levels of Genetic Diversity within Nilo-Saharan Populations: Implications for Human Adaptation.
Am J Hum Genet 107: 2020 473-486
5
SNPs in IL4 and IFNG show no protective associations with human African trypanosomiasis in the Democratic Republic of the Congo: a case-control study.
AAS Open Res 3: 2020 35
0
Analysis of Structural Variants Previously Associated With ALS in Europeans Highlights Genomic Architectural Differences in Africans.
Neurol Genet 9: 2023 e200077
1
Polygenic risk scores for disease risk prediction in Africa: current challenges and future directions.
Genome Med 15: 2023 87
0
The genetic legacy of the expansion of Bantu-speaking peoples in Africa.
Nature 625: 2024 540-547
3